Showing results (2051-2060 of 2,107) with videos related to

Sort By:
Pageof 211
Nature Communications|August 5, 2024
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancerPengfei Xu, Joy C Yang, Bo Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2019
Ancient trash mounds unravel urban collapse a century before the end of Byzantine hegemony in the southern LevantGuy Bar-Oz, Lior Weissbrod, Tali Erickson-Gini, et al.
American Journal of Respiratory and Critical Care Medicine|December 8, 2018
Oral Vitamin C (500 mg/d) to Pregnant Smokers Improves Infant Airway Function at 3 Months (VCSIP). A Randomized TrialCindy T McEvoy, Lyndsey E Shorey-Kendrick, Kristin Milner, et al.
Nature Biomedical Engineering|April 24, 2019
Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffoldsXi Tian, Michael E Werner, Kyle C Roche, et al.
Science Translational Medicine|January 7, 2021
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Irene Scarfò, Rebecca C Larson, et al.
Cell Reports Methods|June 1, 2026
Temporal control of sgRNA library activation unlocks large-scale in vivo CRISPR screensSilvia Fenoglio, Yi Yu, James Tepper, et al.
International Archives of Allergy and Immunology|August 22, 2018
Prevalence of Atopy following Mass Drug Administration with Albendazole: A Study in School Children on Flores Island, IndonesiaSteven L Staal, Sarika K L Hogendoorn, Sophie A Voets, et al.
Acta Neuropathologica Communications|April 12, 2019
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasisTerje Sundstrøm, Lars Prestegarden, Francisco Azuaje, et al.
Nature Medicine|February 27, 2026
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trialMatthew D Galsky, Charlene Mantia, Michaela Bowden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancerNeil E Martin, Thomas B Brunner, Krystina D Kiel, et al.
Pageof 211